Drimva

Loyal

Vice President, CMC Regulatory Affairs

$280K–$340K

Remote - US +1 · Remote · Director · Full-time · Posted Oct 2, 2026

Location
Remote - US
Remote
Experience
18+ years in regulatory affairs, including 10+ years in senior regulatory leadership roles within sponsor organizations.
Education
Ph.D. in Pharmaceutical Sciences, Chemical Engineering, Chemistry, or a related scientific discipline, or equivalent bio-technical experience and expertise.

About the job

Leads Loyal’s global CMC regulatory strategy and operations across its veterinary drug pipeline, from development through approval and post-approval lifecycle management.

What you'll do

  • Own CMC filing strategy, submission content, agency interactions, and post-approval regulatory obligations.
  • Build and lead the CMC regulatory organization, infrastructure, governance, and procedures.
  • Advise executive leadership on regulatory strategy, feasibility, and risk; coordinate with CMC, Quality, and other teams.

What they ask for

  • 18+ years of progressive regulatory affairs experience, including 10+ years in senior regulatory leadership roles within sponsor organizations.
  • Deep small-molecule CMC expertise, including OSD formulation, manufacturing-process strategy, submission authorship, and post-approval change management.
  • Track record leading CMC regulatory teams, successful agency interactions, and bringing at least one product to approval (NDA, MAA, or equivalent).
  • Ph.D. in Pharmaceutical Sciences, Chemical Engineering, Chemistry, or a related scientific discipline, or equivalent bio-technical experience and expertise.

Nice to have

  • Primary experience in human health pharmaceutical or biotech environments; animal health experience is a plus.
  • Experience with FDA CVM and veterinary drug approvals (NADA/ANADA), or with EMA and major Asian agencies (PMDA, NMPA, or equivalents).

Pay

$280,000 - $340,000 (base salary)

Tools

ICH guidelines, eCTD, FDA CVM, NADA, ANADA, EMA, PMDA, NMPA

Model-written summary · the original posting is authoritative

First seen Oct 29, 2026 · Last verified Nov 5, 2026 (UTC)